IOPS Technology During Cannnulation of Contralateral Limb in EVAR

Not yet recruiting

• Conditions: Abdominal Aortic Aneurysm; Abdominal Aortic Aneurysm Without Rupture; Radiation Exposure

• Registration Number: NCT06570785
• Lead Sponsor: Clinical Centre of Serbia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-8-21
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Not yet recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Inclusion Criteria:<br><br> - All patients (over 18 years of age) with infrarenal AAA treated between 1st<br> September 2024 and 1st May 2025 undergoing standard EVAR according to the IFU<br><br>Exclusion Criteria:<br><br> - Patients who are pregnant<br><br> - Patients who are under 40 years of age<br><br> - Patients who have symptomatic or ruptured AAA<br><br> - Patients with more advanced AAA: juxtarenal, pararenal, suprarenal, thoracic,<br> thoracoabdominal AAA<br><br> - Non-atherosclerotic origin of disease: dissection, connective tissue disorders,<br> mycotic AAA, posttraumatic AAA<br><br> - Patients who were treated in a conservative manner<br><br> - Patients undergoing open surgery<br><br> - Patients undergoing more advanced treatment options: fenestrated/branched EVAR,<br> endostaplers, chimney EVAR, iliac branch devices, etc.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of participants with technical success of gate catheterisation;Fluoroscopic time per participant required for cannulation

Secondary Outcome Measures

Name	Time	Method
Clock time per participant required for cannulation;Radiation dose per participant during cannulation